Vol 65, No 4 (2014)
Review paper
Published online: 2014-08-29

open access

Page views 2777
Article views/downloads 3493
Get Citation

Connect on Social Media

Connect on Social Media

Acromegaly — a novel view of the patient. Polish proposals for diagnostic and therapeutic procedures in the light of recent reports

Marek Bolanowski, Marek Ruchała, Wojciech Zgliczyński, Beata Kos-Kudła, Agata Bałdys-Waligórska, Grzegorz Zieliński, Tomasz Bednarczuk, Alicja Hubalewska-Dydejczyk, Grzegorz Kamiński, Bogdan Marek, Jacek Daroszewski, Ryszard Waśko, Andrzej Lewiński
DOI: 10.5603/EP.2014.0045
Endokrynol Pol 2014;65(4):326-331.

Abstract

is usually delayed and is often associated with the development of various complications causing premature mortality. In patients with hypertension, heart failure, diabetes, and arthropathy that is non-specific for age, attention should be paid to the occurrence of somatic signs of acromegaly. As a screening test, insulin-like growth factor-1 (IGF-1) concentration should be assessed. Further diagnostic and treatment procedures are possible in specialised centres. The first-line therapy is selective transsphenoidal adenomectomy. Patients with a good prognosis related to a surgical removal of the pituitary tumour should be referred only to centres experienced in performing this type of procedure, after pharmacological preparation. Other patients, and those who have not recovered after surgical treatment, should be subjected to long-term pharmacotherapy with long-acting somatostatin analogues. In each case, the complications of acromegaly should be followed-up long-term and actively treated. This proposed new recommendation should be helpful for the management of patients with acromegaly. (Endokrynol Pol 2014; 65 (4): 326–331)